CD8A and neoplasm: These discouraging results were explained by a later study showing that subcutaneous vaccination with gp100 peptide emulsified in IFA sequestered antigen-primed CD8+ T cells at the vaccination site, leading to exhaustion, apoptosis, and reduced number of antigen-specific T cells within the tumor (136, 137).